We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study) (AIR)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01499927
First Posted: December 26, 2011
Last Update Posted: December 19, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
  Purpose
Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Condition Intervention
Infection as Complication of Medical Care Other: electronic reminders

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • duration of intravenous antiinfective therapy until switching [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • costs (per year, per day and patient) [ Time Frame: 1 year ]
  • defined daily doses (per 100 days) [ Time Frame: 1 year ]
  • duration of hospitalization [ Time Frame: 1 year ]
  • ratio of narrow to broad-spectrum antibiotics [ Time Frame: 1 year ]
  • requests for consultations [ Time Frame: 1 year ]

Enrollment: 74766
Study Start Date: January 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders
Other: electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders
Other Name: computerized decision support
No Intervention: no electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents without computerized decision support

Detailed Description:
Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • all in-patients in treatment with an intravenous antiinfective for >60h,
  • hospitalized in a ward with computerized physician order entry (cpoe)

Exclusion criteria:

  • outpatients,
  • ward without cpoe,
  • no intravenous antiinfective treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01499927


Locations
Switzerland
University Hospital Zurich, Center for Clinical Research
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Juerg Blaser, Professor University Hospital Zurich, Center for Clinical Research
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01499927     History of Changes
Other Study ID Numbers: FZMI-KEK-ZH-Nr. 2010-0457
First Submitted: November 15, 2011
First Posted: December 26, 2011
Last Update Posted: December 19, 2013
Last Verified: December 2013

Keywords provided by University of Zurich:
Early reassessment of intravenous antiinfective therapy

Additional relevant MeSH terms:
Anti-Infective Agents